Related Experiment Video
Updated: Mar 22, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
[LRRC3B is Downregulated in Non-small Cell Lung Cancer and Connected with Cell Proliferation and Invasion]
Liang Kan1, Meng Zhang1, Ping He1
1Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Background:
LRRC3B expression is downregulated in many kinds of malignant tumors and it is regarded as tumor inhibition protein. However, the expression pattern and biological effect are still unclear in non-small cell lung cancer (NSCLC). Study of human cancer microarray showed LRRC3B was downregulated in breast cancer and colorectal cancer, which declares that LRRC3B takes part in tumor formation. This study is to investigate the expression of LRRC3B in lung cancer cell lines and the influence of LRRC3B during cell proliferation, invasion and cell cycle.
Methods:
The expression of LRRC3B was detected through Western blot and Realtime RT-PCR. MTT assay, colony formation assay and matrigel invasion assay were performed to explore the effect of LRRC3B on cell proliferation, invasion and cell cycle. LRRC3B siRAN was transfected in lung cancer cell line H3255, and then the effect of LRRC3B on cell proliferation, invasion and cell cycle was analyzed.
Results:
During 4 of 9 lung cancer cell lines, the expression of LRRC3B is downregulated compared with normal epithelial cells. Cell proliferation and invasion were inhibited in A549 and H460 after LRRC3B transfected. LRRC3B suppressed the progress of cell cycle and downregulated the expression of cyclin D1 and MMP9. The activity of proliferation and invasion was promoted after LRRC3B was knocked out in H3255.
Conclusions:
LRRC3B expression downreguated in lung cancer cell lines and LRRC3B could inhibit lung cancer cell proliferation, invasion and cell cycle progress. LRRC3B could be a new target for lung cancer therapy. .
Insights
Leucine-rich repeat-containing protein 3B (LRRC3B) is downregulated in lung cancer, inhibiting cell proliferation and invasion. This suggests LRRC3B is a potential therapeutic target for non-small cell lung cancer (NSCLC).
Area of Science:
- Oncology
- Molecular Biology
Background:
- Leucine-rich repeat-containing protein 3B (LRRC3B) is a known tumor suppressor, downregulated in various cancers.
- Its role in non-small cell lung cancer (NSCLC) remains largely uncharacterized.
- Previous studies indicate LRRC3B downregulation in breast and colorectal cancers.
Purpose of the Study:
- To investigate LRRC3B expression in NSCLC cell lines.
- To elucidate the biological functions of LRRC3B in lung cancer cell proliferation, invasion, and cell cycle progression.
Main Methods:
- LRRC3B expression analyzed via Western blot and Real-time RT-PCR.
- Cell proliferation assessed using MTT and colony formation assays.
- Cell invasion evaluated through matrigel invasion assays.
- LRRC3B knockdown and overexpression studies performed in NSCLC cell lines (H3255, A549, H460).
Main Results:
- LRRC3B expression was found to be downregulated in 4 out of 9 NSCLC cell lines.
- LRRC3B overexpression inhibited proliferation and invasion in A549 and H460 cells.
- LRRC3B suppressed cell cycle progression and reduced cyclin D1 and MMP9 expression.
- LRRC3B knockout promoted proliferation and invasion in H3255 cells.
Conclusions:
- LRRC3B is downregulated in NSCLC cell lines.
- LRRC3B acts as an inhibitor of lung cancer cell proliferation, invasion, and cell cycle progression.
- LRRC3B represents a promising therapeutic target for NSCLC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

